As of 2025-10-25, the EV/EBITDA ratio of Inovio Pharmaceuticals Inc (INO) is -1.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INO's latest enterprise value is 123.82 mil USD. INO's TTM EBITDA according to its financial statements is -98.15 mil USD. Dividing these 2 quantities gives us the above INO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 14.1x | 13.7x |
| Forward P/E multiples | 15.3x - 50.0x | 32.6x |
| Fair Price | (28.26) - (26.04) | (42.81) |
| Upside | -1312.9% - -1217.8% | -1937.2% |
| Date | EV/EBITDA |